What's new

Plasma master file certificates

Plasma master file certificates

Feb 9, 2025 0

Plasma master file certificates

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Da...

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogen...

PSUSA/00000408/202405

PSUSA/00000408/202405

Feb 9, 2025 0

PSUSA/00000408/202405

Biologics Working Party

Biologics Working Party

Feb 9, 2025 0

Biologics Working Party

Biosimilar Medicinal Products Working Party

Biosimilar Medicinal Products Working Party

Feb 9, 2025 0

Biosimilar Medicinal Products Working Party

Cardiovascular Working Party

Cardiovascular Working Party

Feb 9, 2025 0

Cardiovascular Working Party

Central Nervous System Working Party

Central Nervous System Working Party

Feb 9, 2025 0

Central Nervous System Working Party

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide...

Vaccines Working Party

Vaccines Working Party

Feb 9, 2025 0

Vaccines Working Party

Methodology Working Party

Methodology Working Party

Feb 9, 2025 0

Methodology Working Party

3Rs Working Party

3Rs Working Party

Feb 9, 2025 0

3Rs Working Party

Quality Working Party

Quality Working Party

Feb 9, 2025 0

Quality Working Party

Rheumatology/Immunology Working Party

Rheumatology/Immunology Working Party

Feb 9, 2025 0

Rheumatology/Immunology Working Party

Haematology Working Party

Haematology Working Party

Feb 9, 2025 0

Haematology Working Party

Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Repaglinide Krka, repa...

Questions and answers clinic on post-authorisation procedure management in IRIS, Online, from 8 January 2025, 14:00 (CET) to 8 January 2025, 15:00 (CET)

Questions and answers clinic on post-authorisation proc...

Feb 9, 2025 0

Questions and answers clinic on post-authorisation procedure management in IRIS,...

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, ...

Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol...

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Truxima, rituximab, Da...

Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Da...

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, ...

Human medicines European public assessment report (EPAR): Alkindi, hydrocortisone, Date of authorisation: 09/02/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Alkindi, hydrocortison...

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Date of authorisation: 13/03/2001, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025 0

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, D...

20
21
22
23
24

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.